LEWISVILLE, Texas--(BUSINESS WIRE)--Teladoc, Inc. (NYSE: TDOC), the nation’s first and largest telehealth provider, today announced the U.S. Patent and Trademark Office (USPTO) has invalidated the major elements of a telemedicine patent held by American Well Corporation on the basis that they were not patentable because American Well did not invent them. The USPTO took this action at the request of Teladoc. At issue before the USPTO were the same elements of the American Well patent that a Massachusetts federal court declared invalid earlier this year on a separate basis.
“For more than a year, we have challenged American Well’s patent portfolio as invalid, advocating on behalf of the industry so innovation and increased access to health care can continue to thrive,” said Adam Vandervoort, Teladoc chief legal officer. “Teladoc is extremely pleased by the decisions of both the U.S. Patent and Trademark Office and the Massachusetts federal court.”
About Teladoc
Teladoc, Inc. (NYSE:TDOC) is the nation’s leading provider of telehealth services and a pioneering force in bringing the virtual care visit into the mainstream of today’s health care ecosystem. Serving some 6,000 clients — including health plans, health systems, employers and other organizations — more than 15 million members can use phone, mobile devices and secure online video to connect within minutes to Teladoc’s network of more than 3,100 board-certified, state-licensed physicians and behavioral health specialists, 24/7. With national coverage, a robust, scalable platform and a Lewisville, Texas-based member services center staffed by 400 employees, Teladoc offers the industry’s most comprehensive and complete telehealth solution including primary care, behavioral health care, dermatology, tobacco cessation and more. For additional information, visit www.teladoc.com.